
Cell Banking Outsourcing Market by Type (Master Cell Banking, Viral Cell Banking, Working Cell Banking), Cell Type (Non-Stem Cell, Stem Cell), Phase - Global Forecast 2024-2030
Description
Cell Banking Outsourcing Market by Type (Master Cell Banking, Viral Cell Banking, Working Cell Banking), Cell Type (Non-Stem Cell, Stem Cell), Phase - Global Forecast 2024-2030
The Cell Banking Outsourcing Market size was estimated at USD 12.64 billion in 2023 and expected to reach USD 14.57 billion in 2024, at a CAGR 15.59% to reach USD 34.87 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Cell Banking Outsourcing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Banking Outsourcing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Cell Banking Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Advanced Instruments, LLC, BioReliance Corporation, Charles River Laboratories International, Inc.,, Clean Biologics, Cordlife Group Limited, Cryo-Cell International Inc., Cryoviva, ExcellGene SA., Goodwin Biotechnology Inc., GTP Bioways, LifeCell International Pvt. Ltd., Lonza Group Ltd., Merck KGaA, Perfectus Biomed Limited, Reliance Life Sciences Limited, REPROCELL Inc., Sartorius AG, SGS SA, and Texcell SA.
Market Segmentation & Coverage
This research report categorizes the Cell Banking Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Master Cell Banking
Viral Cell Banking
Working Cell Banking
Cell Type
Non-Stem Cell
Stem Cell
Adult Stem Cell Banking
Cord Cell Banking
Dental Stem Cell Banking
Embryonic Stem Cell Banking
IPS Stem Cell Banking
Phase
Bank Characterization & Testing
Bank Preparation
Master Cell Bank Prep
Working Cell Bank Prep
Bank Storage
Cell Storage Stability Testing
Master Cell Bank Prep
Working Cell Bank Prep
Gene Expression Testing
Gene Sequencing Testing
Karyology Testing
Safety Testing
Microbial Cell Banks
Viral Cell Banks
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Cell Banking Outsourcing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Banking Outsourcing Market?
3. What are the technology trends and regulatory frameworks in the Cell Banking Outsourcing Market?
4. What is the market share of the leading vendors in the Cell Banking Outsourcing Market?
5. Which modes and strategic moves are suitable for entering the Cell Banking Outsourcing Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
184 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Cell Banking Outsourcing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing demand for gene therapy and stem cell therapy
- 5.1.1.2. Rising prevalence of chronic diseases and need for biopharmaceutical production
- 5.1.1.3. Government initiatives for the development of stable cell lines and rise in the number of approvals for cell therapies
- 5.1.2. Restraints
- 5.1.2.1. High cost of cell therapies
- 5.1.3. Opportunities
- 5.1.3.1. Development of automation in cord blood processing and storage
- 5.1.3.2. Expanding investments and funding for monoclonal antibodies and stem cell R&D
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulations and legal challenges
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Cell Banking Outsourcing Market, by Type
- 6.1. Introduction
- 6.2. Master Cell Banking
- 6.3. Viral Cell Banking
- 6.4. Working Cell Banking
- 7. Cell Banking Outsourcing Market, by Cell Type
- 7.1. Introduction
- 7.2. Non-Stem Cell
- 7.3. Stem Cell
- 7.4.1. Adult Stem Cell Banking
- 7.4.2. Cord Cell Banking
- 7.4.3. Dental Stem Cell Banking
- 7.4.4. Embryonic Stem Cell Banking
- 7.4.5. IPS Stem Cell Banking
- 8. Cell Banking Outsourcing Market, by Phase
- 8.1. Introduction
- 8.2. Bank Characterization & Testing
- 8.3. Bank Preparation
- 8.4.1. Master Cell Bank Prep
- 8.4.2. Working Cell Bank Prep
- 8.4. Bank Storage
- 8.5.1. Cell Storage Stability Testing
- 8.5.2. Master Cell Bank Prep
- 8.5.3. Working Cell Bank Prep
- 8.5. Gene Expression Testing
- 8.6. Gene Sequencing Testing
- 8.7. Karyology Testing
- 8.8. Safety Testing
- 8.9.1. Microbial Cell Banks
- 8.9.2. Viral Cell Banks
- 9. Americas Cell Banking Outsourcing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Cell Banking Outsourcing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Cell Banking Outsourcing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Advanced Instruments, LLC
- 13.1.2. BioReliance Corporation
- 13.1.3. Charles River Laboratories International, Inc.,
- 13.1.4. Clean Biologics
- 13.1.5. Cordlife Group Limited
- 13.1.6. Cryo-Cell International Inc.
- 13.1.7. Cryoviva
- 13.1.8. ExcellGene SA.
- 13.1.9. Goodwin Biotechnology Inc.
- 13.1.10. GTP Bioways
- 13.1.11. LifeCell International Pvt. Ltd.
- 13.1.12. Lonza Group Ltd.
- 13.1.13. Merck KGaA
- 13.1.14. Perfectus Biomed Limited
- 13.1.15. Reliance Life Sciences Limited
- 13.1.16. REPROCELL Inc.
- 13.1.17. Sartorius AG
- 13.1.18. SGS SA
- 13.1.19. Texcell SA
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. CELL BANKING OUTSOURCING MARKET RESEARCH PROCESS
- FIGURE 2. CELL BANKING OUTSOURCING MARKET SIZE, 2023 VS 2030
- FIGURE 3. CELL BANKING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. CELL BANKING OUTSOURCING MARKET DYNAMICS
- FIGURE 7. CELL BANKING OUTSOURCING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. CELL BANKING OUTSOURCING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
- FIGURE 10. CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. CELL BANKING OUTSOURCING MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
- FIGURE 12. CELL BANKING OUTSOURCING MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. CELL BANKING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. CELL BANKING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.